1. Antidepressants and Risk of Liver Cancer: A Systematic Review and Meta-Analysis
    Xiaofeng Chen et al, 2023, Annals of Pharmacotherapy CrossRef
  2. Refocusing the Use of Psychiatric Drugs for Treatment of Gastrointestinal Cancers
    Mariana Avendaño-Félix et al, 2020, Frontiers in Oncology CrossRef
  3. Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion
    Xia Pan et al, 2023, Cell Cycle CrossRef
  4. Antidepressant Use and Mortality Among Patients With Hepatocellular Carcinoma
    Kuan-Lun Huang et al, 2023, JAMA Network Open CrossRef
  5. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
    Alina L. Capatina et al, 2020, Targets of Cancer Diagnosis and Treatment CrossRef
  6. Synergistic Enhancement of Antitumor Effects by Combining Abemaciclib with Desipramine
    Yan Li et al, 2024, International Journal of Molecular Sciences CrossRef
  7. HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways
    Qiqi Liu et al, 2022, Advanced Science CrossRef
  8. Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype
    Karina Kofman et al, 2024, Progress in Biophysics and Molecular Biology CrossRef
  9. Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells
    Fu-Chia Shih et al, 2024, Life Sciences CrossRef
  10. Study effect of traditional chemotherapy compared with the effect of combination (chemotherapeutic plus paroxetine) on cell line of multiple myeloma
    Zahraa A. H. Al-Tameemi et al, 2023, THE SECOND INTERNATIONAL SCIENTIFIC CONFERENCE (SISC2021): College of Science, Al-Nahrain University CrossRef
  11. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
    Mohammad S. Alzahrani et al, 2024, Cell Biochemistry and Biophysics CrossRef
  12. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study
    Vincent Chin-Hung Chen et al, 2019, Journal of Affective Disorders CrossRef
  13. Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
    Bálint Rácz et al, 2023, Antibiotics CrossRef
  14. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro
    Wei-Ting Chen et al, 2019, International Journal of Molecular Sciences CrossRef
  15. Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
    Antonio Asensi-Cantó et al, 2022, Cancers CrossRef
  16. Repurposing antidepressants for anticancer drug discovery
    Yihui Song et al, 2022, Drug Discovery Today CrossRef